Onderneming Taysha Gene Therapies, Inc.
Aandelen
TSHA
US8776191061
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,45 USD | +2,51% | -0,41% | +38,42% |
09/04 | TAYSHA GENE THERAPIES, INC. : Piper Sandler ontvangt een koopadvies | ZM |
21/03 | TAYSHA GENE THERAPIES, INC. : Chardan Research handhaaft koopadvies | ZM |
Vakgebied
Aantal werknemers: 52
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Adeno-Associated Viruses-based Gene Therapies
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 15 | 100,0 % | +517,55% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 01-08-20 |
President | 58 | 01-07-20 | |
Fred Porter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jim Rouse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sean McAuliffe
PRN | Corporate Officer/Principal | - | 01-06-20 |
Emily McGinnis
LAW | General Counsel | - | 01-04-20 |
Tracy M. Porter
HRO | Human Resources Officer | - | 26-01-21 |
Mary Newman
PRN | Corporate Officer/Principal | 65 | 13-05-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 31-08-20 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 01-03-20 |
Sean Stalfort
BRD | Director/Board Member | 54 | 21-06-23 |
President | 58 | 01-07-20 | |
Director/Board Member | 63 | 23-11-20 | |
Alison Long
BRD | Director/Board Member | - | 01/11 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 187 018 275 | 140 693 475 ( 75,23 %) | 0 | 75,23 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,42% | 458 mln. | |
+1,77% | 42,86 mld. | |
+45,72% | 41,36 mld. | |
+12,24% | 42,74 mld. | |
-8,83% | 27,68 mld. | |
+7,44% | 25,15 mld. | |
-23,01% | 18,63 mld. | |
+30,56% | 12,37 mld. | |
-1,82% | 11,92 mld. | |
+8,35% | 11,21 mld. |
- Beurs
- Aandelen
- Koers TSHA
- Onderneming Taysha Gene Therapies, Inc.